12694821

Source:http://linkedlifedata.com/resource/pubmed/id/12694821

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027819, umls-concept:C1516476, umls-concept:C1522449, umls-concept:C2603343
pubmed:issue	1
pubmed:dateCreated	2003-4-15
pubmed:abstractText	To assess the effect of local radiation administered to primary disease sites in children with high-risk neuroblastoma.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA13539
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Isotretinoin
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0360-3016
pubmed:author	pubmed-author:GerbingRobert BRB, pubmed-author:Haas-KoganDaphne ADA, pubmed-author:HaaseGerald MGM, pubmed-author:MatthayKatherine KKK, pubmed-author:SeegerRobert CRC, pubmed-author:SelchMichaelM, pubmed-author:StramDaniel ODO, pubmed-author:SwiftPatrick SPS
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	56
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	28-39
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:12694821-Adolescent, pubmed-meshheading:12694821-Antineoplastic Agents, pubmed-meshheading:12694821-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12694821-Bone Marrow Purging, pubmed-meshheading:12694821-Bone Marrow Transplantation, pubmed-meshheading:12694821-Child, pubmed-meshheading:12694821-Child, Preschool, pubmed-meshheading:12694821-Cisplatin, pubmed-meshheading:12694821-Combined Modality Therapy, pubmed-meshheading:12694821-Cyclophosphamide, pubmed-meshheading:12694821-Dose Fractionation, pubmed-meshheading:12694821-Doxorubicin, pubmed-meshheading:12694821-Hematologic Diseases, pubmed-meshheading:12694821-Hepatic Veno-Occlusive Disease, pubmed-meshheading:12694821-Humans, pubmed-meshheading:12694821-Infant, pubmed-meshheading:12694821-Isotretinoin, pubmed-meshheading:12694821-Life Tables, pubmed-meshheading:12694821-Neoplasm Recurrence, Local, pubmed-meshheading:12694821-Neoplasms, Radiation-Induced, pubmed-meshheading:12694821-Neoplasms, Second Primary, pubmed-meshheading:12694821-Neuroblastoma, pubmed-meshheading:12694821-Radiotherapy, Adjuvant, pubmed-meshheading:12694821-Remission Induction, pubmed-meshheading:12694821-Risk, pubmed-meshheading:12694821-Survival Analysis, pubmed-meshheading:12694821-Survival Rate, pubmed-meshheading:12694821-Transplantation, Autologous, pubmed-meshheading:12694821-Whole-Body Irradiation
pubmed:year	2003
pubmed:articleTitle	Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
pubmed:affiliation	Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. hkogan@radonc17.ucsf.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study